Western African nation The Gambia, where the deaths of at least 66 children last year was linked to an Indian cough syrup, has introduced a pre-shipment inspection and testing for Indian pharmaceuticals.
In place since July 1, the requirement follows the country’s Medicines Control Agency (MCA) regulation mandating pre-shipment document verification, physical inspection, quality control testing and issuance of Clean Report of Inspection and Analysis (CRIA) for pharmaceuticals. The country expects the proposal to address issues related to substandard and counterfeit medicines entering the country.
Also read: The lowdown on ‘substandard’ cough syrups
